Understanding how the immune system responds to tuberculosis infection
Elucidating the path to type I IFNs in TB infection
This study is looking at how our immune system responds to the bacteria that cause tuberculosis (TB) to find out how we can better fight the infection, and it's designed for anyone interested in understanding more about TB and improving treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11056044 on NIH RePORTER |
What this research studies
This research investigates the immune response triggered by the bacterium that causes tuberculosis (TB), focusing on type I interferons, which are crucial for fighting infections. The study aims to uncover the cellular and molecular mechanisms that lead to either the clearance of the infection or its progression. By utilizing advanced genetic tools and a mouse model, researchers will explore how various cellular pathways interact during TB infection. This could lead to new insights into how to enhance the immune response against TB.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with tuberculosis or are at high risk of developing the disease.
Not a fit: Patients who do not have tuberculosis or are not at risk for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and strategies for preventing tuberculosis infections.
How similar studies have performed: Previous research has shown promising results in understanding immune responses to infections, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Barczak, Amy K — Massachusetts General Hospital
- Study coordinator: Barczak, Amy K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.